Answers are grounded in this paper and cite their sources.
Cyclic GMP-AMP synthase (cGAS) detects viral and mislocalized host DNA to initiate antiviral immunity. Productive cGAS activation requires coordinated DNA accessibility and engagement, catalytic activation, higher-order assembly, and appropriate subcellular context. Viruses counteract this pathway by shielding DNA, disrupting cGAS-DNA interactions, modifying or depleting cGAS, remodeling cGAS assemblies and condensates, and exploiting nuclear regulatory mechanisms. Similar phenotypes, such as reduced production of 2'3'-cyclic GMP-AMP (2'3'-cGAMP), or loss of cGAS puncta, can arise from distinct molecular lesions, complicating mechanistic interpretation. Here, we organize viral cGAS antagonism around discrete but interconnected functional states, and emphasize the experimental evidence needed to distinguish direct inhibition from secondary effects. This framework integrates viral genome biology, host factors, cellular compartments, and infection stage to clarify conserved and context-dependent strategies of immune evasion.
No takes yet. Share an insight, caveat, or question.
Da et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: